J&J | Omløpsmidler




Current Assets Endring Dato
AbbVie USD 25.58B 2.2B 2024-12
Abbott USD 23.66B 146M 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
CONMED USD 640.01M 992K 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Indivior 799M 65M 2024-09
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
J&J USD 55.89B 2.64B 2024-12
Medtronic USD 22.51B 75M 2025-01
Merck USD 38.78B 1.58B 2024-12
Merit Medical Systems USD 923.77M 154.54M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 724.49M 28.33M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12
Zoetis USD 5.99B 296M 2024-12



J&J Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.